Skip to main content

Advertisement

SpringerLink
Log in

Update on accelerated partial-breast irradiation

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Progress in radiotherapy technology, particularly the advent of CT-guided simulation and three-dimensional conformal planning, has given the radiation oncologist the ability to precisely treat part of the breast, instead of the whole breast, using either brachytherapy or external-beam techniques. Treating such a limited area may allow the course of treatment for patients with earlystage breast cancer to be drastically shortened and could reduce toxicity to other organs. This article summarizes the rationale for accelerated partial-breast irradiation (APBI), techniques for performing it, and outcome to date of studies of APBI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Recht A: Breast carcinoma: in situ and early-stage invasive cancers. In Clinical Radiation Oncology. Edited by Gunderson LL. New York: Churchill Livingstone; 2000:968–998.

    Google Scholar 

  2. Fisher B, Anderson S, Bryant J, et al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233–1241.

    Article  PubMed  Google Scholar 

  3. Veronesi U, Cascinelli N, Mariani L, et al.: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227–1232.

    Article  PubMed  Google Scholar 

  4. Arriagada R, Le MG, Rochard F, et al. for the IGR Breast Cancer Group: Conservative treatment versus mastectomy in early breast cancer: patterns of failure with fifteen years of follow-up. J Clin Oncol 1996, 14:1558–1564.

    PubMed  CAS  Google Scholar 

  5. Pierce LJ, Griffith KA, Hayman JA, et al.: Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys 2005, 61:1317–1327.

    Article  PubMed  Google Scholar 

  6. Cabioglu N, Hunt KK, Buchholz TA, et al.: Improving local control with breast-conserving therapy. Cancer 2005, 104:20–29.

    Article  PubMed  Google Scholar 

  7. Pierce S, Recht A, Lingos TI, et al.: Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992, 23:915–923.

    PubMed  CAS  Google Scholar 

  8. Lingos T, Recht A, Vicini F, et al.: Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991, 21:355–360.

    PubMed  CAS  Google Scholar 

  9. Taghian A, Assaad S, Niemierko A, et al.: Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001, 23:1806–1811.

    Article  Google Scholar 

  10. Cuzick J, Stewart H, Rutqvist L, et al.: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994, 12:447–453.

    PubMed  CAS  Google Scholar 

  11. Coen JJ, Taghian AG, Kachnic L, et al.: Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003, 55:1209–1215.

    Article  PubMed  Google Scholar 

  12. Powell S, Cooke J, Parsons C: Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol 1990, 18:213–218.

    Article  PubMed  CAS  Google Scholar 

  13. Taghian A, de Vathaire F, Terrier P, et al.: Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991, 21:361–368.

    PubMed  CAS  Google Scholar 

  14. Smith TE, Lee D, Turner BC, et al.: True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000, 48:1281–1289.

    Article  PubMed  CAS  Google Scholar 

  15. Recht A, Come SE, Troyan S, et al.: Local-regional recurrence after mastectomy or breast-conserving therapy. In Diseases of the Breast, edn 2. Edited by Harris JR, MorrowM, et al. Philadelphia: Lippincott Williams & Wilkins;2000:731–748.

    Google Scholar 

  16. Recht A, Houlihan MJ: Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer: a review. Ann Surg 1995, 222:9–18.

    Article  PubMed  CAS  Google Scholar 

  17. Vicini FA, Goldstein NS, Pass H, Kestin LL: Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2004, 60:86–94. Important data suggesting selection criteria and treatment volume for partial breast irradiation.

    Article  PubMed  Google Scholar 

  18. Mazeron J, Simon JM, Crook J, et al.: Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant. Int J Radiat Oncol Biol Phys 1991, 21:1173–1177.

    PubMed  CAS  Google Scholar 

  19. Lawenda BD, Taghian AG, Kachnic LA, et al.: Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003, 56:671–680.

    Article  PubMed  Google Scholar 

  20. Vicini FA, Baglan KL, Kestin LL, et al.: Accelerated treatment of breast cancer. J Clin Oncol 2001, 19:1993–2001. Summary of the William Beaumont Hospital experience with interstitial implantation. This is one of the first complete reports on APBI using implants.

    PubMed  CAS  Google Scholar 

  21. Wazer DE, Berle L, Graham R, et al.: Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002, 53:889–897.

    Article  PubMed  Google Scholar 

  22. Polgar C, Sulyok Z, Fodor J, et al.: Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002, 80:121–129. Summary of the National Institute of Oncology (Budapest) experience and very early results of their randomized trial.

    Article  PubMed  Google Scholar 

  23. Perera F, Engel J, Holliday R, et al.: Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol 1997, 65:263–268.

    Article  PubMed  CAS  Google Scholar 

  24. Wazer D, Lowther D, Boyle T, et al.: Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2001, 50:107–111.

    Article  PubMed  CAS  Google Scholar 

  25. Cuttino L, Todor D, Arthur DW: CT-guided multi-catheter insertion technique for partial breast brachytherapy: reliable target coverage and dose homogeneity. Brachytherapy 2005, 4:10–17.

    Article  PubMed  Google Scholar 

  26. Suh WW, Pierce LJ, Vicini FA, et al.: A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005, 62:790–796.

    Article  PubMed  Google Scholar 

  27. Arthur DW, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 2005, 23:1726–1735. Up-to-date comprehensive review article describing the techniques used in APBI.

    Article  PubMed  Google Scholar 

  28. Dickler A, Kirk M, Choo J, et al.: Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2004, 59:469.

    Article  PubMed  Google Scholar 

  29. Astrahan MA, Jozsef G, Streeter OE Jr: Optimization of MammoSite therapy. Int J Radiat Oncol Biol Phys 2004, 58:220–232.

    Article  PubMed  Google Scholar 

  30. Keisch M, Vicini F, Kuske RR, et al.: Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003, 55:289–293.

    Article  PubMed  Google Scholar 

  31. Keisch M, Vicini F, Kuske R, et al.: Two-year outcome with the MammoSite breast brachytherapy applicator: factors associated with optimal cosmetic results when performing partial breast irradiation. Int J Radiat Oncol Biol Phys 2003, 57:S315.

    Article  Google Scholar 

  32. Shah N, Tenenholz T, Arthur D, et al.: MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 2004, 101:727–734.

    Article  PubMed  Google Scholar 

  33. Richards G, Berson A, Rescigno J, et al.: Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 2004, 11:739–746.

    Article  PubMed  Google Scholar 

  34. Vicini F, Beitsch PD, Quiet CA, et al.: First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Cancer 2005, 104:1138–1148. First report for the registry trial that was designed to collect data on the clinical use of the MammoSite. Eighty-seven institutions participated in this trial, which included 1419 patients. This paper reports the early results regarding acute toxicity and cosmesis.

    Article  PubMed  Google Scholar 

  35. Zannis VJ, Walker LC, Barclay-White B, et al.: Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter. Am J Surg 2003, 186:383–385.

    Article  PubMed  Google Scholar 

  36. Harper JL, Jenrette JM, Vanek KN, et al.: Acute complications of MammoSite brachytherapy: a single institution’s initial clinical experience. Int J Radiat Oncol Biol Phys 2005, 61:169–174.

    Article  PubMed  Google Scholar 

  37. Shah NM, Wazer DE: The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation. Semin Radiat Oncol 2005, 15:100–107.

    Article  PubMed  Google Scholar 

  38. Veronesi U, Orecchia R, Luini A, et al.: A preliminary report of intraoperative radiotherapy (IORT) in limitedstage breast cancers that are conservatively treated. Eur J Cancer 2001, 37:2178–2183.

    Article  PubMed  CAS  Google Scholar 

  39. Veronesi U, Orecchia R, Luini A, et al.: Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 2005, 242:101–106.

    Article  PubMed  Google Scholar 

  40. Orecchia R, Veronesi U: Intraoperative electrons. Semin Radiat Oncol 2005, 2:76–83.

    Article  Google Scholar 

  41. Vaidya JS, Tobias JS, Baum M, et al.: TARGeted intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol 2005, 15:84–91.

    Article  PubMed  Google Scholar 

  42. Tobias JS, Vaidya JS, Keshtgar M, et al.: Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. Br J Radiol 2004, 77:279–284.

    Article  PubMed  CAS  Google Scholar 

  43. Vicini F, Remouchamps V, Wallace M, et al.: Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003, 57:1247–1253.

    Article  PubMed  Google Scholar 

  44. Formenti SC, Truong MT, Goldberg JD, et al.: Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2004, 60:493–504.

    Article  PubMed  Google Scholar 

  45. Taghian A, Kozak KR, Doppke KP, et al: Initial dosimetric experience using simple three-dimensional-conformal external-beam accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2005, in press.

  46. Rosenstein BS, Lymberis SC, Formenti SC: Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys 2004, 60:1393–1404.

    Article  PubMed  Google Scholar 

  47. Powell SN, Doppke KP, Chen GT, et al.: Set-up uncertainty in accelerated partial-breast irradiation using 3D-conformal external beam radiotherapy: a companion study to a prospective phase I ongoing trial. Int J Radiat Oncol Biol Phys 2004, 60:S400-S401.

    Article  Google Scholar 

  48. Ribeiro G, Dunn G, Swindell R, et al.: Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol 1990, 2:27–34.

    Article  CAS  Google Scholar 

  49. Ribeiro G, Magee B, Swindell R, et al.: The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 1993, 5:278–283. Only randomized trial with long-term results, although the investigators used outmoded patient selection criteria and treatment techniques.

    Article  CAS  Google Scholar 

  50. Polgar C, Major T, Mangel LC, et al.: Sole HDR-brachytherapy after breast conserving surgery: 4 year results of a pilot study and initial findings of a randomized Phase III trial [abstract]. Radiother Oncol 2000, 55(Suppl 1):31.

    Article  Google Scholar 

  51. National Surgical Adjuvant Breast and Bowel Project (NSABP B-39 / RTOG 0413). A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer. Vol 2005. http://www. nsabp.pitt.edu/B-39.htm, 2005.

  52. King T, Bolton JS, Kuske RR, et al.: Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg 2000, 180:299–304. One of the first large studies of this approach.

    Article  PubMed  CAS  Google Scholar 

  53. Arthur DW, Koo D, Zwicker RD, et al.: Partial breast brachytherapy after lumpectomy: low dose rate and high dose rate experience. Int J Radiat Oncol Biol Phys 2003, 56:681–689.

    Article  PubMed  Google Scholar 

  54. Krishnan L, Jewell WR, Tawfik OW, et al.: Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 2001, 7:91–96.

    Article  PubMed  CAS  Google Scholar 

  55. Jewell W, Krishnan L, Reddy EK, et al.: Intraoperative implantation radiation therapy plus lumpectomy for carcinoma of the breast. Arch Surg 1987, 122:687–690.

    PubMed  CAS  Google Scholar 

  56. Fentiman I, Poole C, Tong D, et al.: Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 1996, 32A:608–611.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 02114, Boston, MA, USA

    Alphonse G. Taghian MD, PhD

Authors
  1. Alphonse G. Taghian MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abram Recht MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taghian, A.G., Recht, A. Update on accelerated partial-breast irradiation. Curr Oncol Rep 8, 35–41 (2006). https://doi.org/10.1007/s11912-006-0007-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-006-0007-7

Keywords

Search

Navigation